HomeXENE • NASDAQ
add
Xenon Pharmaceuticals Inc
Previous close
$41.94
Day range
$58.00 - $62.91
Year range
$26.74 - $62.91
Market cap
5.22B USD
Avg Volume
850.12K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 22.07M | 22.57% |
Net income | -105.26M | -60.25% |
Net profit margin | — | — |
Earnings per share | -1.31 | -55.95% |
EBITDA | -109.16M | -42.11% |
Effective tax rate | -0.51% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 548.89M | -12.45% |
Total assets | 633.16M | -20.67% |
Total liabilities | 51.40M | 18.89% |
Total equity | 581.76M | — |
Shares outstanding | 83.19M | — |
Price to book | 5.77 | — |
Return on assets | -44.23% | — |
Return on capital | -47.41% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -105.26M | -60.25% |
Cash from operations | -81.48M | -49.82% |
Cash from investing | 62.70M | -36.35% |
Cash from financing | 113.54M | 836.00% |
Net change in cash | 94.65M | 71.80% |
Free cash flow | -44.67M | -40.64% |
About
Founded
1996
Headquarters
Website
Employees
364
